Organigram Recruits for as Many as 75 Roles Based in Moncton, New Brunswick
June 03 2021 - 6:42PM
Business Wire
- Company hiring for positions including product research and
development, production, cultivation and other support roles
- Recently launched Organigram/BAT Centre of Excellence, formed
to focus on developing the next generation of cannabis products,
created a number of initial positions as it ramps up plans
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a
leading producer of cannabis, is pleased to announce that it is
currently recruiting for as many as 75 positions, across most
functional areas of the Company. Positions include those in
Operations, Production, Sanitation, Cultivation, Sales, Marketing,
Research, and Quality Assurance.
The Company is also pleased to announce the official launch of
the Center of Excellence outlined in the Company’s Product
Development Collaboration Agreement with BAT, a leading,
multi-category consumer goods business with extensive plant-based
expertise and development capabilities. As the companies ramp up
plans for the Moncton-based Organigram/BAT Centre of Excellence
(“CoE”), a number of initial positions have been created, including
innovation-focused roles such as scientists and product developers.
The CoE has been established to focus on the development of
innovative and differentiated cannabis vapour and oral products as
well as other IP and technologies, with an initial focus on CBD.
Over time, the employee count for the Centre of Excellence is
expected to increase.
“As we continue to monitor and respond to the impact of COVID-19
on our industry, as well as the evolving and dynamic nature of
customer demand, we are pleased to expand our teams and draw on and
contribute to the experience and expertise of the local community,”
says Paolo De Luca, Chief Strategy Officer, Organigram. “At
Organigram, our goal is to continue to build a world-class
workforce, identifying roles that support the development of new,
innovative and industry-leading products.”
In 2020, PricewaterhouseCoopers (PwC) assessed Organigram’s
economic contribution to the New Brunswick and Canadian economies,
as well as the range of wider socio-economic benefits associated
with Organigram’s operations. Among other highlights, the report
found that, since 2017, in New Brunswick alone, Organigram had
contributed more than $284 million to the GDP.1
Organigram will also be hosting a career fair on June 5th, 2021
from 10am to 1pm AST at its Moncton facility, 320 Edinburgh Drive,
Door 55. Please note the event is only open to potential job
seekers.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc., a licensed producer of cannabis and
cannabis-derived products in Canada and The Edibles and Infusions
Corporation, a cannabis infused soft chew and confectionary
manufacturer in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED and
Trailblazer. Organigram's facility is located in Moncton, New
Brunswick with another leased manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
the outcome of recruitment efforts and factors and risks as
disclosed in the Company’s most recent annual information form,
management’s discussion and analysis and other Company documents
filed from time to time on SEDAR (see www.sedar.com) and filed or
furnished to the Securities and Exchange Commission on EDGAR (see
www.sec.gov). Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. Although the Company believes that the
assumptions and factors used in preparing the forward-looking
information in this news release are reasonable, undue reliance
should not be placed on such information and no assurance can be
given that such events will occur in the disclosed time frames or
at all. The forward-looking information included in this news
release are made as of the date of this news release and the
Company disclaims any intention or obligation, except to the extent
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
1 PwC Organigram Holdings Inc. Socio-economic Impact Study June
2020
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210603006100/en/
For Career Fair information: Tina Shannon Vice President
of Human Resources tina.shannon@organigram.ca For Media
enquiries: Marlo Taylor mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024